The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential sideeffects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.
A 21-year-old with diffuse thinning hair is considering RU58841 due to sideeffects from topical finasteride and is asking for the lowest effective dose and time to see results from RU58841 users.
The user is currently using alfatradiol and fluridil for hair loss and is considering adding low-dose topical finasteride but is concerned about potential sideeffects due to past mental health issues. They are seeking others' experiences with these treatments and their effectiveness.
A peptide-based delivery system for finasteride shows promise in reducing systemic sideeffects while maintaining hair growth effectiveness. Combining this with other treatments like minoxidil and RU58841 could enhance results with lower systemic absorption.
The conversation discusses hair loss treatments, specifically progesterone therapy with hydrocortisone butyrate, and the use of dutasteride and finasteride. Opinions vary on the effectiveness and sideeffects of these treatments, with some users advocating for acceptance of balding if treatments are not suitable.
Finasteride can cause gynecomastia due to hormonal imbalances. Management includes consulting an endocrinologist and using aromatase inhibitors like anastrozole or supplements like DIM and zinc.
Prolonged use of topical minoxidil and finasteride can lead to neuroendocrine and autonomic dysfunction, causing severe sensitivity and sideeffects. Recovery involves avoiding these treatments, supporting neurosteroid recovery, calming the sympathetic system, and rebuilding scalp health naturally.
A 33-year-old male has been using finasteride 1mg for nearly 4 years, experiencing stabilized hair loss and some regrowth but also cognitive issues. He is considering reducing the dose or switching to topical finasteride with minoxidil to maintain hair while minimizing cognitive sideeffects.
The user is considering using Tacrolimus Solution and topical Dutasteride to avoid shedding caused by Minoxidil, which they fear may lead to facial sideeffects. They are also concerned about scalp sensitivity and are exploring different treatment bases to manage seborrheic dermatitis.
Minoxidil can cause scalp flaking and dryness, often due to its alcohol content. Switching to foam minoxidil or using antifungal shampoos like Ketoconazole may help reduce these sideeffects.
The user experienced severe sideeffects from finasteride, including depression and anxiety, but recovered with DHT injections, sleep medication, and Ayurvedic treatments. They now maintain hair health with minoxidil, PRP therapy, and a good diet, advising against self-diagnosis and recommending consulting a doctor.
Finasteride and dutasteride may not significantly impact meibomian gland function since these glands do not rely on DHT. Some users report dry eyes and other sideeffects from finasteride, but these may be influenced by other factors or medications.
A 25-year-old experiencing genetic hair loss used minoxidil, biotin, and cystine but stopped due to routine fatigue, leading to worsened hair loss and unwanted body hair growth. They are hesitant about finasteride due to potential sideeffects and are seeking advice on effective treatments.
Combining finasteride and dutasteride with activities that raise testosterone may increase the risk of sideeffects like gynecomastia, depending on genetic predisposition and hormone levels. It's advised to check hormone levels to assess the risk.
A male in his early 40s, who experienced sideeffects from finasteride, used 2.5% topical spironolactone for one year with no sideeffects but minimal regrowth. He plans to try a 5% spironolactone solution next.
Caffeine may interfere with oral minoxidil because caffeine increases blood pressure while minoxidil lowers it. Users discuss potential interactions and effects on hair loss treatment.
People discussed treatments for hair thinning on the sides, mentioning Finasteride, Dutasteride, Pyrilutamide, and RU58841. One person is currently using Finasteride and seeking advice on its effectiveness for this issue.
The user experienced severe sideeffects from finasteride, including anxiety and libido issues, and is currently using topical minoxidil and microneedling. They are considering trying dutasteride but are concerned about potential sideeffects.
A user experienced severe sideeffects, including symptoms of congestive heart failure, after using excessive doses of minoxidil for beard growth. They stopped using it due to financial reasons, but still suffer from lingering symptoms and are advised to seek medical attention.
Clascoterone (Breezula) showed positive results for treating hair loss without affecting cortisol levels. Opinions vary, with some users optimistic about its potential and others critical of its effectiveness compared to existing treatments like finasteride.
After taking finasteride for 192 days, the user experienced sideeffects like depressed mood and decreased libido, along with worsening hair thinning and scalp issues. Despite consulting a dermatologist, the user's hair condition and scalp itchiness have not improved.
The user applies a topical solution containing minoxidil, finasteride, dutasteride, retinoic acid, and hydrocortisone to address scalp inflammation and is considering adding cetirizine to the mix. They are calculating the correct amount of cetirizine to add to their formula and have paused this approach to retry oral minoxidil.
Stopping finasteride may reduce water retention or alter fat distribution, leading to a leaner face. Hormonal changes, like reduced DHT or increased estrogen, could cause these effects.
The conversation discusses using topical finasteride with propylene glycol, which causes scalp dryness or dandruff. The user also uses Nizoral, Nioxin, and DHT oil, and considers using a scalp conditioner to alleviate dryness.
A user is experiencing facial bloating from low-dose topical finasteride due to high estradiol levels and is seeking advice on using DIM to manage this issue, including dosage and brand recommendations.
Switching from propylene glycol to glycerin in topical finasteride may reduce systemic absorption and sideeffects while maintaining local scalp DHT suppression. Concerns exist about glycerin's ability to deliver the full dose to hair follicles.
Experimenting with trestolone as a treatment for hair loss in an attempt to avoid DHT-related treatments such as finasteride and dutasteride, and discussing the potential effects of its receptor selectivity on the androgen receptors in the scalp.